AstraZeneca shares up amid talk of possible takeover bid by Pfizer

US shares in the Anglo-Swedish pharmaceutical company rose almost 6% on the prospect of what would be the biggest foreign takeover of a British business

Investors reacted to speculation that AstraZeneca could be the subject of a takeover bid by US rival Pfizer by pushing its share price up in New York trading.

While shares in the Anglo-Swedish pharmaceutical company were not trading on the London stock exchange on Monday because of the Easter holiday, its US shares rose almost 6% on the prospect of what would be the biggest foreign takeover of a British business.

Continue reading…
Pharmaceuticals industry | The Guardian

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us